載入...
BCL-2 as therapeutic target for hematological malignancies
Disruption of the physiologic balance between cell proliferation and cell death is an important step of cancer development. Increased resistance to apoptosis is a key oncogenic mechanism in several hematological malignancies and, in many cases, especially in lymphoid neoplasias, has been attributed...
Na minha lista:
| 發表在: | J Hematol Oncol |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5946445/ https://ncbi.nlm.nih.gov/pubmed/29747654 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-018-0608-2 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|